CD16a Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Siplizumab | MEDI-507; TCD-601 | Phase 2 Clinical | Catholic University Of Louvain, Itb-Med Llc | Multiple Myeloma; Amyotrophic Lateral Sclerosis; Kidney Failure, Chronic; Plaque psoriasis; Anemia, Sickle Cell; Lymphoma; Lymphoma, T-Cell; Hidradenitis Suppurativa; Hepatitis, Autoimmune; Lymphoma, Extranodal NK-T-Cell; Psoriasis; Cholangitis, Sclerosing; Diabetes Mellitus, Type 1; Liver Diseases; Myelodysplastic Syndromes; Neoplasms; Graft vs Host Disease; Kidney Diseases; Liver Cirrhosis; Renal Insufficiency; Rejection of liver transplantation; Leukemia; End Stage Liver Disease; Rejection of renal transplantation | Details |
| Alefacept | LFA-3-TIP; LFA-3(92)IgG; BG-9273; BG-9712; ASP-0485 | Phase 1 Clinical | Astellas Pharma Inc | Diabetes Mellitus, Type 1; Graft vs Host Disease; Psoriasis; Anemia, Aplastic; Lymphoma | Details |
| SBT-11-5301 | SBT115301 | Phase 1 Clinical | Sonoma Biotherapeutics Inc | Autoimmune Diseases | Details |
| PIT-565 | PIT-565 | Phase 1 Clinical | Novartis Pharma Ag | Lymphoma, B-Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Lupus Erythematosus, Systemic; Leukemia, Myeloid, Acute | Details |